Skip to main content
Equibles

CITADEL ADVISORS LLC

Position in NEOG — Neogen Corp

CIK 1423053 MIAMI, FL
Back to NEOG Full portfolio

Position in NEOG

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$9,277,030
-$4,670,452 QoQ
Shares Held
998,604
-50.0% QoQ
Ownership
0.459%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in NEOG Over Time

Shares Held

Position Value (USD)

Derivatives in NEOG

reported options exposure · as of Mar 31, 2026
CallValue
$3,388,063
CallShares
364,700
PutValue
$5,597,225
PutShares
602,500

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Medical Devices

Healthcare · as of Mar 31, 2026

CITADEL ADVISORS LLC holds $1,870,037,695 across 83 Medical Devices names. NEOG ranks #25 (0.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 BSX
Boston Scientific Corp
 4,217,314 $264,636,453
2 ABT
Abbott Laboratories
 1,915,846 $196,699,908
3 GMED
Globus Medical Inc
 1,966,114 $169,400,381
4 GKOS
GLAUKOS Corp
 1,446,926 $155,776,052
5 DXCM
Dexcom Inc
 2,091,872 $131,369,561
6 ZBH
Zimmer Biomet Holdings, Inc.
 1,378,665 $124,658,889
7 GEHC
GE HealthCare Technologies Inc.
 1,293,268 $92,054,816
8 MDT
Medtronic plc
 982,741 $85,154,507

All Filings in NEOG

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $5,597,225 602,500
2026-03-31 $9,277,030 998,604
2026-03-31 $3,388,063 364,700
2025-12-31 $3,569,094 510,600
2025-12-31 $3,996,183 571,700
2025-12-31 $13,947,482 1,995,348
2025-09-30 $918,739 160,900
2025-09-30 $4,942,272 865,547
2025-09-30 $4,727,880 828,000
2025-06-30 $190,244 39,800
2025-06-30 $13,162,097 2,753,577
2025-06-30 $3,496,092 731,400
2025-03-31 $17,340 2,000
2025-03-31 $456,909 52,700
2025-03-31 $1,725,330 199,000
2024-12-31 $291,651 24,024
2024-12-31 $389,694 32,100
2024-12-31 $422,472 34,800
2024-09-30 $179,867 10,700
2024-09-30 $18,888,539 1,123,649
2024-09-30 $1,094,331 65,100
2024-06-30 $43,795,697 2,802,028
2024-06-30 $990,942 63,400
2024-06-30 $914,355 58,500
2024-03-31 $178,314 11,300
2024-03-31 $976,782 61,900
2023-12-31 $448,453 22,300
2023-12-31 $1,872,241 93,100
2023-12-31 $2,332,840 116,004
2023-09-30 $1,347,858 72,700
2023-09-30 $77,270,918 4,167,795
2023-09-30 $1,114,254 60,100
2023-06-30 $2,264,175 104,100
2023-06-30 $75,146,293 3,455,002
2023-06-30 $828,675 38,100
2023-03-31 $529,672 28,600
2023-03-31 $744,504 40,200
2023-03-31 $64,146,223 3,463,619
2022-12-31 $21,923,021 1,439,463
2022-12-31 $705,149 46,300
2022-12-31 $321,353 21,100
2022-09-30 $38,211,582 2,735,260
2022-09-30 $634,238 45,400
2022-09-30 $326,898 23,400
2022-06-30 $4,453,999 184,890
2022-06-30 $373,395 15,500
2022-03-31 $243,636 7,900
2022-03-31 $496,524 16,100
2022-03-31 $1,237,455 40,125
2021-12-31 $258,837 5,700

Report a Problem

Category
Description
Email (optional, for follow-up)